retatrutide phase 2 results obesity nejm 2023 π¨Breaking: Retatrutide's first 3 T2D data just dropped. βΈ A1C: β2.0% at 40 weeks βΈ Weight: β36.6 lbs (β16.8%) at 12 mg βΈ No weight loss plateau β curve still descending 𧬠R3TA is a next-generation
Description
Powell, C
The upper outer arm over the triceps area is the approved injection site, though most manufacturers recommend having another person administer arm injections due to accessibility challenges

People drink 3+ liters of plain water daily, feel terrible, and cannot figure out why

Robinson LJ, Thompson JM, Gallagher P, Goswami U, Young AH, Ferrier IN, et al

During physical activity, the body shifts between carbohydrates and fats depending on intensity and duration

doi: 10.3389/fimmu.2021.714177 7 KimWEganJM
